서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 10 of 10

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2017-05	Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial Twelves, Chris; Cortes, Javier; O'Shaughnessy, Joyce; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; Rugo, Hope S. European Journal of Cancer, Vol.76, pp.205-215	DOI
2017-12	The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies Cortes, Javier; Im, Seock-Ah; Holgado, Esther; Perez-Garcia, Jose M.; Schmid, Peter; Chavez-MacGregor, Mariana Cancer Treatment Reviews, Vol.61, pp.53-60	DOI
2018-09	Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: A pooled analysis of randomised PALOMA clinical studies Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang; Johnston, Stephen European Journal of Cancer, Vol.101, pp.123-133	DOI
2018-11	Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3 Cristofanilli, Massimo; DeMichele, Angela; Giorgetti, Carla; Turner, Nicholas C.; Slamon, Dennis J.; Im, Seock-Ah; Masuda, Norikazu; Verma, Shailendra; Loi, Sherene; Colleoni, Marco; Theall, Kathy Puyana; Huang, Xin; Liu, Yuan; Bartlett, Cynthia Huang European Journal of Cancer, Vol.104, pp.21-31	DOI
2022-12	Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3 Rugo, Hope S.; Im, Seock-Ah; Joy, Anil A.; Shparyk, Yaroslav; Walshe, Janice M.; Sleckman, Bethany; Loi, Sherene; Theall, Kathy Puyana; Kim, Sindy; Huang, Xin; Bananis, Eustratios; Mahtani, Reshma; Finn, Richard S.; Diéras, Véronique Breast, Vol.66, pp.324-331	DOI
2023-07	Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Park, Kyunghee; Wen, Ji; Lee, Kyung-Hun; Choi, Yoon-La; Lee, Won-Chul; Min, Ahrum; Bonato, Vinicius; Park, Seri; Ram, Sripad; Lee, Dae-Won; Kim, Ji-Yeon; Lee, Su Kyeong; Lee, Won-Woo; Lee, Jisook; Kim, Miso; Kim, Hyun Seon; Weinrich, Scott L.; Ryu, Han Suk; Kim, Tae Yong; Dann, Stephen; Kim, Yu-Jin; Fernandez, Diane R.; Koh, Jiwon; Wang, Shuoguo; Park, Song Yi; Deng, Shibing; Powell, Eric; Ravi, Rupesh Kanchi; Bienkowska, Jadwiga; Rejto, Paul A.; Park, Woong-Yang; Kan, Zhengyan Genome Medicine, Vol.15 No.1, p. 55	DOI
2023-08	Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant Neven, P.; Fasching, P.A.; Chia, S.; Jerusalem, G.; De, Laurentiis M.; Im, S.-A.; Petrakova, K.; Bianchi, G.V.; Martin, M.; Nusch, A.; Sonke, G.S.; De, la Cruz-Merino L.; Beck, J.T.; Zarate, J.P.; Wang, Y.; Chakravartty, A.; Wang, C.; Slamon, D.J. Breast Cancer Research, Vol.25 No.1, p. 103	DOI
2023-08	Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant Neven, P.; Fasching, P. A.; Chia, S.; Jerusalem, G.; De Laurentiis, M.; Im, S.-A.; Petrakova, K.; Bianchi, G. V.; Martín, M.; Nusch, A.; Sonke, G. S.; De la Cruz-Merino, L.; Beck, J. T.; Zarate, J. P.; Wang, Y.; Chakravartty, A.; Wang, C.; Slamon, D. J. Breast Cancer Research, Vol.25(1):103	view file DOI
2023-12	Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Kim, Se Hyun; Im, Seock-Ah; Suh, Koung Jin; Lee, Kyung-Hun; Kim, Min Hwan; Sohn, Joohyuk; Park, Yeon Hee; Kim, Ji-Yeon; Jeong, Jae Ho; Lee, Kyoung Eun; Choi, In Sil; Park, Kyong Hwa; Kim, Hee-Jun; Cho, Eun Kyung; Park, So Yeon; Kim, Milim; Kim, Jee Hyun European Journal of Cancer, Vol.195, p. 113386	DOI

1